CUMYL-PICA

From WikiMD's WELLNESSPEDIA

Chemical structure of CUMYL-PICA

CUMYL-PICA is a synthetic cannabinoid that has been identified in various designer drug products. It is part of a class of compounds that are designed to mimic the effects of tetrahydrocannabinol (THC), the active component of cannabis. These substances are often used recreationally and can have potent psychoactive effects.

Chemical Structure[edit]

CUMYL-PICA is chemically classified as an indole-based synthetic cannabinoid. Its full chemical name is 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide. The structure of CUMYL-PICA includes an indole core, which is a common feature among many synthetic cannabinoids. The presence of a cyanobutyl group and a phenylpropan-2-yl group distinguishes it from other compounds in this class.

Pharmacology[edit]

Synthetic cannabinoids like CUMYL-PICA act as agonists at the cannabinoid receptors, primarily the CB1 receptor and CB2 receptor. These receptors are part of the endocannabinoid system, which plays a role in regulating mood, memory, appetite, and pain sensation. The binding affinity and efficacy of CUMYL-PICA at these receptors can lead to effects similar to those of THC, but often with greater potency and unpredictability.

Effects and Risks[edit]

The effects of CUMYL-PICA can include euphoria, altered perception, and relaxation. However, due to its high potency, it can also cause adverse effects such as anxiety, paranoia, tachycardia, and in severe cases, psychosis or seizures. The use of synthetic cannabinoids has been associated with numerous health risks, and their legal status varies by region.

Legal Status[edit]

The legal status of CUMYL-PICA varies worldwide. In many countries, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. Regulatory agencies continue to monitor and update the legal status of synthetic cannabinoids as new compounds are identified and their effects are better understood.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=CUMYL-PICA&oldid=6624076"